MOST NOTEWORTHY:

• Merriman upgraded shares of Syneron Medical (NASDAQ:ELOS) to Buy from Neutral following the Q1 results to reflect the introduction of LipoLite and the company's global distribution channel. They believe shares can trade towards the $22-$26 level.
  
• Jefferies upgraded Cellcom Israel (NYSE:CEL) to Buy from Hold following the company's Q1 results to reflect its improved EBITDA outlook.
  
• Morgan Keegan upgraded GATX (NYSE:GMT) to Outperform from Market Perform as they believe the company has increased opportunities to deploy capital given the current state of the market for railcars, which should result in share outperformance.
  
• Suntrust raised TNS, Inc (NYSE:TNS) to Buy from Neutral citing improved execution and the global shift towards electronic transactions.

• Chevron (NYSE:CVX) was raised at UBS to Buy from Neutral.
  
• RBC Capital upgraded TeleTech Holdings (NASDAQ:TTEC) to Sector Perform from Underperform.
  
• Citigroup upgraded SINA Corp (NASDAQ:SINA) to Buy from Hold.

Analyst upgrades: ELOS, CEL, GMT and TNS originally appeared on BloggingStocks on Thu, 15 May 2008 10:54:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• B. Riley believes NDS Group (NASDAQ: NNDS) is in an attractive space with 42M digital TV subscribers, increasing competition between TV service providers and declining digital deployment costs, starting shares with a Buy rating and $66.50 target.
• KeyBanc McDonald initiated shares of Payless ShoeSource Inc (NYSE: PSS) with a Buy rating and $42 target.
• Calyon started Southern Union Co (NYSE: SUG) with a Buy rating and $38 target and sees positive catalysts over the next 12-18 months, including a potential takeover or monetization and the formal creation of an MLP.
• Take-Two Interactive Software (NASDAQ: TTWO) was started with a Hold rating at Needham. The firm finds it unlikely that shares will outperform until new management sets forth their new plan, which is expected to take 3-6 months.

• Credit Suisse imitated Akamai Technologies, Inc (NASDAQ: AKAM) with an Outperform rating and $65 target.
• American Technology believes Cadence Pharmaceuticals, Inc's (NASDAQ: CADX) two late-stage products fill an important, unmet medical need and started the company with a Buy rating and $24 target.
• UBS started shares of NuStar GP Holdings, LLC (NYSE: NSH) with a Neutral rating and $30 target.
• TeleTech Holdings, Inc (NASDAQ: TTEC) was initiated with a Buy rating at Merrill Lynch.

Analyst initiations 4-09-07: Akamai Tech & Take-Two Interactive initiated today originally appeared on BloggingStocks on Mon, 09 Apr 2007 11:07:00 EST. Please see our terms for use of feeds.

Continue reading IPO & secondary preview - week of March 26, 2007

IPO & secondary preview - week of March 26, 2007 originally appeared on BloggingStocks on Tue, 27 Mar 2007 18:12:00 EST. Please see our terms for use of feeds.